Target
Fibroblast growth factor receptor 3 [399-806]
Ligand
BDBM436194
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
>1000±n/a nM
Citation
 Kong, NXZhou, CZheng, Z Heterocyclic compounds used as FGFR inhibitors US Patent  US10590109 Publication Date 3/17/2020 
Target
Name:
Fibroblast growth factor receptor 3 [399-806]
Synonyms:
FGFR3 | FGFR3_HUMAN | Fibroblast growth factor receptor 3 (FGFR3)(aa 399-806) | JTK4
Type:
Enzyme Catalytic Domain
Mol. Mass.:
45160.69
Organism:
Homo sapiens (Human)
Description:
aa 399-806
Residue:
408
Sequence:
RSPPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGEGPTLANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSAPFEQYSPGGQDTPSSSSSGDDSVFAHDLLPPAPPSSGGSRT
  
Inhibitor
Name:
BDBM436194
Synonyms:
US10590109, Compound 12
Type:
Small organic molecule
Emp. Form.:
C22H24N6O6
Mol. Mass.:
468.4626
SMILES:
COCCOc1cc(NC(=O)N(C)c2ccc(CN3CCOCC3=O)c(C=O)n2)ncc1C#N
Structure:
Search PDB for entries with ligand similarity: